Your session is about to expire
← Back to Search
Behavioral Intervention
TeleHealth Resources for Alcoholism (THRIVE Trial)
N/A
Recruiting
Led By Katie Witkiewitz
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
At least 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to three year follow-up period
Awards & highlights
THRIVE Trial Summary
This trial will study how mindfulness-based relapse prevention via video helps people with alcohol use disorder reduce or stop drinking. It will also look at how widely it's adopted and how it supports long-term recovery in underserved areas.
Who is the study for?
This trial is for adults over 18 with alcohol use disorder (AUD) who have tried to reduce or stop drinking in the last 3 months. Participants must be willing to use a smart device, understand English or Spanish, and not require inpatient detoxification. They should also not have severe mental health issues like psychosis or mania.Check my eligibility
What is being tested?
The THRIVE study tests if mindfulness-based relapse prevention via video conferencing helps long-term recovery from AUD compared to online support groups. It looks at how well this method works across communities, including underserved areas.See study design
What are the potential side effects?
Since the interventions involve non-medical treatments such as online support and mindfulness training, typical medical side effects are not expected; however, participants may experience emotional discomfort when discussing their experiences with alcohol.
THRIVE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
THRIVE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to three year follow-up period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to three year follow-up period
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Recovery from AUD
Secondary outcome measures
Addiction Cycle - Executive Function Scale
Addiction Cycle - Incentive Salience Scale
Addiction Cycle - Negative Emotionality Scale
+11 moreTHRIVE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness-based relapse preventionExperimental Treatment1 Intervention
The MBRP condition will be based on an existing rolling group treatment manual, which consists of eight 60-minute sessions. Each session will begin with a brief mindfulness practice and a discussion of "what is mindfulness?" and the role mindfulness may play in recovery. The themes are repeated every eight sessions, but in every session the participant is bringing a new direct moment experience to the practices in that session. The groups will also consist of people in various stages of recovery and familiarity with the material, which can make for richer discussions of the material led by the group members themselves. Participants who are randomized to receive rolling MBRP treatment will also have access to the Thrive Recovery smart phone app, which includes audio-guided MBRP meditations for participants to practice in daily life.
Group II: Referral to online mutual support groupsActive Control1 Intervention
The referral group will consist of a brief 1:1 meeting with a research team member who will provide an orientation to online mutual support and discuss the SMART Recovery, Alcoholics Anonymous (AA), and other virtual meeting options and to discuss how to access mutual support via these platforms. Individuals will also have an opportunity to review the process of attending online groups, and will discuss technology issues that might arise during groups. The session will be 20-30 minutes in length.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness-based relapse prevention
2015
N/A
~20
Find a Location
Who is running the clinical trial?
University of New MexicoLead Sponsor
372 Previous Clinical Trials
3,528,359 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
802 Previous Clinical Trials
1,365,015 Total Patients Enrolled
Katie WitkiewitzPrincipal InvestigatorUniversity of New Mexico
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this scientific investigation still enrolling participants?
"Indeed, the information found on clinicaltrials.gov verifies that this research endeavour is actively seeking participants. Initiated and last updated in September/October of 2023, it requires 430 individuals to be recruited from one medical centre."
Answered by AI
What is the current enrollment rate of individuals in this clinical trial?
"Affirmative, clinicaltrials.gov documents this medical research as currently enrolling participants. It was first advertised on September 13th 2023 and the existing information has been modified most recently on October 6th of that same year. 430 people are necessary to be recruited from 1 center for this study."
Answered by AI
Who else is applying?
What site did they apply to?
University of New Mexico
What portion of applicants met pre-screening criteria?
Met criteria
Why did patients apply to this trial?
I am ready to make a change and willing to give the treatment a try.
PatientReceived no prior treatments
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger